Abstract
It is estimated that 34.3 million people worldwide are now living with human immunodeficiency virus (HIV) infection (United Nations Programme on HIV/AIDS & World Health Organization, 2000), a retrovirus that causes acquired immunodeficiency syndrome (AIDS). Since the beginning of the HIV pandemic, almost 19 million individuals have died from AIDS (2.8 million of these in 1999). Despite significant medical advances in the treatment of the disease, the rate at which individuals are becoming infected continues to increase. Close to 6 million new individuals were infected in 1998, primarily in the developing world (see Table 1). Sub-Saharan African countries are the most profoundly impacted, with up to one quarter of young adults being HIV seropositive.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adams, R. L., Boake, C., & Crain, C. (1982). Bias in neuropsychological test classification related to education, age, and ethnicity. Journal of Consulting and Clinical Psychology, 50, 143–145.
Albert, S. M., Marder, K. M., Dooneief, G., Bell, K., Sano, M., Todak, G., & Stem, Y. (1995). Neuropsychologic impairment in early HIV infection: A risk factor for work disability. Archives of Neurology,52, 525–530.
Albert, S. M., Weber, C. M., Todak, G., Polanco, C., Clouse, R., McElhiney, M., Rabkin, J., Stern, Y., & Marder, K. (1999). An observed performance test of medication management ability in HIV: Relation to neuropsychological status and medication adherence outcomes. AIDS and Behavior, 3(2),121–128.
American Academy of Neurology. (1998). Evaluation and management of intracranial mass lesions in AIDS. Report of the Quality Standards Subcommittee of the American Academy of Neurology.Neurology, 50, 21–26.
American Academy of Neurology AIDS Task Force. (1991). Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Neurology, 41, 778–785.
American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4thed.). Washington, DC: Author.
Atkinson, J. H., & Grant, I. (1994). Natural history of neuropsychiatric manifestations of HIV disease.Psychiatric Clinics of North America, 17(1), 17–33.
Atkinson, J. H., & Grant, I. (1997). Neuropsychiatry of human immunodeficiency virus infection. In J. R. Berger & R. M. Levy (Eds.), AIDS and the nervous system (2nd ed., pp. 419–449). Philadelphia:Lippincott-Raven.
Atkinson, J. H., Jr., Grant, I., Kennedy, C. J., Richman, D. D., Spector, S. A., & McCutchan, J. A. (1988).Prevalence of psychiatric disorders among men infected with human immunodeficiency virus. A controlled study. Archives of General Psychiatry, 45, 859–864.
Bacellar, H., Muñoz, A., Miller, E. N., Cohen, B. A., Besley, D., Seines, O. A., Becker, J. T., & McArthur,J. C. (1994). Temporal trends in the incidence of HIV-1-related neurologic diseases: Multicenter AIDS Cohort Study, 1985–1992. Neurology, 44, 1892–1900.
Baldeweg, T., Catalan, J., Lovett, E., Gruzelier, J., Riccio, M., & Hawkins, D. (1995). Long-term zidovudine reduces neurocognitive deficits in HIV-1 infection. AIDS, 9, 589–596.
Bamborschke, S., Wullen, T., Huber, M., Neveling, M., Baldamus, C. A., Korn, K., & Jahn, G. (1992). Early diagnosis and successful treatment of acute cytomegalovirus encephalitis in a renal transplant-recipient. Journal of Neurology, 239, 205–208.
Becker, J. T., Caldararo, R., Lopez, O. L., Dew, M. A., Dorst, S. K., & Banks, G. (1995). Qualitative features of the memory deficit associated with HIV infection and AIDS: Cross-validation of a discriminant function classification scheme. Journal of Clinical and Experimental Neuropsychology, 17,134–142.
Bloom, F. E., & Rausch, D. M. (1997). HIV in the brain: Pathology and neurobehavioral consequences (meeting report). Journal of Neurovirology, 3, 102–109.
Bornstein, R. A., Nasrallah, H. A., Para, M. F., Fass, R. J., Whitacre, C. C., & Rice, R. R. (1991). Rate of CD4 decline and neuropsychological performance in HIV infection. Archives of Neurology, 48, 704–707.
Bornstein, R. A., Nasrallah, H. A., Para, M. F., Whitacre, C. C., Rosenberger, P., Fass, R. J., & Rice, R.(1992). Neuropsychological performance in asymptomatic HIV infection. Journal of Neuropsychiatry and Clinical Neurosciences, 4, 386–394.
Brew, B. J., Rosenblum, M., Cronin, K., & Price, R. W. (1995). AIDS dementia complex and HIV-1 brain infection: Clinical-virological correlations. Annals of Neurology, 38, 563–570.
Brown, G. R. (1995). The use of methylphenidate for cognitive decline associated with HIV disease.International Journal of Psychiatry in Medicine, 25(1), 21–37.
Brown, G. R., Rundell, J. R., McManis, S. E., Kendall, S. N., Zachary, R., & Temoshok, L. (1992).Prevalence of psychiatric disorders in early stages of HIV infection. Psychosomatic Medicine, 54,588–601.
Butters, N., Grant, I., Haxby, J., Judd, L. L., Martin, A., McClelland, J., Pequegnat, W., Schacter, D., & Stover, E. (1990). Assessment of AIDS-related cognitive changes: Recommendations of the NIMH Workshop on Neuropsychological Assessment Approaches. Journal of Clinical and Experimental Neuropsychology, 12, 963–978.
Bylsma, S. S., Achim, C. L., Wiley, C. A., Gonzalez, C., Kuppermann, B. D., Berry, C., & Freeman, W. R.(1995). The predictive value of cytomegalovirus retinitis for cytomegalovirus encephalitis in acquired immunodeficiency syndrome. Archives of Ophthalmology, 113(1), 89–95.
Carlin, A. S., & O’Malley, S. (1997). Neuropsychological consequences of drug abuse. In I. Grant & K. M.Adams (Eds.), Neuropsychological assessment of neuropsychiatric disorders (2nd ed., pp. 486–503). New York: Oxford University Press.
Centers for Disease Control. (1999). HIV/AIDS surveillance report (Vol. 11, p. 30).
Chelune, G., & Moehle, K. (1986). Neuropsychological assessment and everyday functioning. In D.Wedding, J. Horton, & J. Webster (Eds.), The neuropsychology handbook: Behavioral and clinical perspectives (pp. 489–525). New York: Springer.
Clifford, D. B., Yiannoutsos, C., Glicksman, M., Simpson, D. M., Singer, E. J., Piliero, P. J., Marra, C. M.,Francis, G. S., McArthur, J. C., Tyler, K. L., Tselis, A. C., & Hyslop, N. E. (1999). HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy [see comments]. Neurology, 52(3), 623–625.
Cournos, F., & McKinnon, K. (1997). HIV seroprevalence among people with severe mental illness in the United States: A critical review. Clinical Psychology Review, 17, 259–269.
Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders. (1997). Safety and tolerability of the antioxidant OPC-14117 in HIV-associated cognitive impairment. Neurology, 49,142–146.
Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders. (1998). A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment. Neurology, 50, 645–651.
Day, J. J., Grant, I., Atkinson, J. H., Brysk, L. T., McCutchan, J. A., Hesselink, J. R., Heaton, R. K.,Weinrich, J. D., Spector, S. A., & Richman, D. D. (1992). Incidence of AIDS dementia in a two-year follow-up of AIDS and ARC patients on an initial phase IIAZT placebo-controlled study: San Diegocohort. Journal of Neuropsychiatry and Clinical Neuroscience, 4, 15–20.
Dew, M. A., Ragni, M. V., & Nimorwicz, P. (1990). Infection with human immunodeficiency virus and vulnerability to psychiatric distress: A study of men with hemophilia. Archives of General Psychiatry, 47, 737–744.
Dew, M. A., Becker, J. T., Sanchez, J., Caldararo, R., Lopez, O. L., Wess, J., Dorst, S. K., & Banks, G. (1997).Prevalence and predictors of depressive, anxiety and substance use disorders in HIV-infected and uninfected men: A longitudinal evaluation. Psychological Medicine, 27, 395–409.
Dore, G. J., Correll, P. K., Li, Y., Kaldor, J. M., Cooper, D. A., & Brew, B. J. (1999). Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS, 13, 1249–1253.
Dragic, T., Litwin, V., Allaway, G. P., Martin, S. R., Huang, Y., Nagashima, K. A., Cayanan, C., Maddon, P.J., Koup, R. A., Moore, J. P., & Paxton, W. A. (1996). HIV-1 entry into CD4 + cells is mediated by the chemokine receptor CC-CKR-5 [see comments]. Nature, 381, 667–673.
Ellis, R. J., Deutsch, R., Heaton, R. K., Marcotte, T. D., McCutchan, J. A., Nelson, J. A., Abramson, I., Thai,L., Atkinson, J. H., Wallace, M. R., Grant, I., & the HNRC Group. (1997a). Neurocognitive impairment is an independent risk factor for death in HIV infection. Archives of Neurology, 54, 416–424.
Ellis, R. J., Hsia, K., Spector, S. A., Nelson, J. A., Heaton, R. K., Wallace, M. R., Abramson, I., Atkinson, J.H., Grant, I., McCutchan, J. A., & the HNRC Group. (1997b). Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. Annals of Neurology, 42, 679–688.
Evans, D. L., Leserman, J., Perkins, D. O., Stern, R. A., Murphy, C., Zheng, B., Gettes, D., Longmate, J. A.,Silva, S. G., van der Horst, C. M., Hall, C. D., Folds, J. D., Golden, R. N., & Petitto, J. M. (1997). Severe life stress as a predictor of early disease progression in HIV infection. American Journal of Psychiatry, 154, 630–634.
Everall, I. P., Luthert, P. J., & Lantos, P. L. (1991). Neuronal loss in the frontal cortex in HIV infection.Lancet, 337, 1119–1121.
Feng, Y., Broder, C. C., Kennedy, P. E., & Berger, E. A. (1996). HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor [see comments]. Science, 272,872–877.
Fernandez, F., Adams, F., Levy, J. K., Holmes, V., Neidhart, M., & Mansell, P. W. A. (1988). Cognitive impairment due to AIDS-related complex and its response to psychostimulants. Psychosomatics,29, 38–46.
Ferrando, S., van Gorp, W., McElhindy, M., Goggin, K., Sewell, M., & Rabkin, J. (1998). Highly active antiretroviral treatment in HIV infection: Benefits for neuropsychological function. AIDS, 12,F65–F70.
Galgani, S., Balestra, P., Narciso, P., Tozzi, V., Sette, P., Pau, F., & Visco, G. (1997). Nimodipine plus zidovudine versus zidovudine alone in the treatment of HIV-1-associated cognitive deficits. AIDS,11, 1520–1521.
Gillespie, S. M., Chang, Y., Lemp, G., Arthur, R., Buchbinder, S., Steimle, A., Baumgartner, J., Rando, T.,Neal, D., Rutherford, G., Schonberger, L., & Janssen, R. (1991). Progressive multifocal leukoencephalopathy in persons infected with human immunodeficiency virus, San Francisco, 1981–1989.Annals of Neurology, 30, 597–604.
Glass, J. D., Wesselingh, S. L., Seines, O. A., & McArthur, J. C. (1993). Clinical-neuropathologic correlations in HIV-associated dementia. Neurology, 43, 2230–2237.
Goggin, K. J., Zisook, S., Heaton, R. K., Atkinson, J. H., Marshall, S., McCutchan, J. A., Chandler, J. L.,Grant, I., & the HNRC Group. (1997). Neuropsychological performance of HIV-1 infected men with major depression. Journal of the International Neuropsychological Society, 3, 457–464.
Grant, I., & Atkinson, J. H. (1995). Psychiatric aspects of acquired immunodeficiency syndrome. In H. I.Kaplen & B. J. Sadock (Eds.), Comprehensive textbook of psychiatry/VI (Vol. VI, pp. 1644–1669).Baltimore: Williams & Williams.
Grant, I., Adams, K. M., Carlin, A. S., Rennick, P., Judd, L. L., & Schooff, K. (1978). The collaborative neuropsychological study of polydrug abusers. Archives of General Psychiatry, 35, 1063–1074.
Grant, I., Atkinson, J. H., Hesselink, J. R., Kennedy, C. J., Richman, D. D., Spector, S. A., & McCutchan, J.A. (1987). Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Annals of Internal Medicine, 107, 828–836.
Grant, I., Olshen, R. A., Atkinson, J. H., Heaton, R. K., Nelson, J., McCutchan, J. A., & Weinrich, J. D.(1993). Depressed mood does not explain neuropsychological deficits in HIV-infected persons.Neuropsychology, 7(1), 53–61.
Grant, I., Heaton, R. K., Atkinson, J. H., & the HNRC Group. (1995). Neurocognitive disorder in HIV-1infection. In M. B. A. Oldstone & L. Vitkovic (Eds.), Current topics in microbiology and immunology. HIV and dementia (Vol. 202, pp. 9–30). Heidelberg: Springer-Verlag.
Harris, M. J., Jeste, D. V., Gleghorn, A., & Sewell, D. D. (1991). New-onset psychosis in HIV-infected patients [see comments]. Journal of Clinical Psychiatry, 52(9), 369–376.
Haverkos, H. W., Turner Jr., J. F., Moolchan, E. T., & Cadet, J. L. (1999). Relative rates of AIDS amongracial/ethnic groups by exposure categories. Journal of the National Medical Association, 91(1),17–24.
Heaton, R. K. (1992). Comprehensive norms for an expanded Halstead-Reitan Battery: A supplement for the WAIS-R. Odessa, FL: Psychological Assessment Resources, Inc.
Heaton, R. K., Grant, I., & Matthews, C. G. (1991). Comprehensive norms for an expanded Halstead-Reitan Battery: Demographic corrections, research findings, and clinical applications. Odessa, FL:Psychological Assessment Resources, Inc.
Heaton, R. K., Velin, R. A., McCutchan, J. A., Gulevich, S. J., Atkinson, J. H., Wallace, M. R., Godfrey, H.P. D., Kirson, D. A., Grant, I., & the HNRC Group. (1994). Neuropsychological impairment in human immunodeficiency virus-infection: Implications for employment. Psychosomatic Medicine, 56(1),8–17.
Heaton, R. K., Grant, I., Butters, N., White, D. A., Kirson, D., Atkinson, J. H., McCutchan, J. A., Taylor, M.J., Kelly, M. D., Ellis, R. J., Wolfson, T., Velin, R., Marcotte, T. D., Hesselink, J. R., Jernigan, T. L.,Chandler, J., Wallace, M., Abramson, I., & the HNRC Group. (1995). The HNRC 500-Neuropsychology of HIV infection at different disease stages. Journal of the International Neuropsychological Society, 1, 231–251.
Heaton, R. K., Marcotte, T. D., Ellis, R. J., Deutsch, R., Abramson, I., Grant, I., & the HNRC Group. (1996a).Neuropsychological profile and prognostic significance of Minor Cognitive/Motor Disorder [Ab-stract]. Journal of Neurovirology, 2, 39.
Heaton, R. K., Marcotte, T. D., White, D. A., Ross, D., Meredith, K., Taylor, M. J., Kaplan, R., & Grant, I.(1996b). Nature and vocational significance of neuropsychological impairment associated with HIV infection. Clinical Neuropsychologist, 10, 1–14.
Heseltine, P. N. R., Goodkin, K., Atkinson, J. H., Vitiello, B., Rochon, J., Heaton, R. K., Eaton, E. M.,Wilkie, F. L., Sobel, E., Brown, S. J., Feaster, D., Schneider, L., Goldschmidts, W. L., & Stover, E. S.(1998). Randomized double-blind placebo-controlled trial of peptide-T for HIV-associated cognitive impairment. Archives of Neurology, 55, 41–51.
Heyes, M., Brew, B., Martin, A., Price, R., Salazar, A., Sidtis, J., Yergey, J., Mouradian, M., Sadler, A.,Keilp, J., Rubinow, D., & Markey, S. (1991). Quinolinic acid in cerebrospinal fluid and serum in HIV infection: Relationship to clinical and neurologic status. Annals of Neurology, 29, 202–209.
Hinkin, C. H., van Gorp, W. G., Satz, P., Weisman, J. D., Thommes, J., & Buckingham, S. (1992).Depressed mood and its relationship to neuropsychological test performance in HIV-1 seropositive individuals. Journal of Clinical and Experimental Neuropsychology, 14, 289–297.
Hinkin, C. H., Castellon, S. A., Hardy, D. J., Granholm, E., & Siegle, G. (1999). Computerized and traditional Stroop task dysfunction in HIV-1 infection. Neuropsychology, 13, 306–316.
Holland, N., Power, C., Matthews, V., Glass, J., Forman, M., & McArthur, J. (1994). Cytomegalovirus encephalitis in acquired immunodeficiency syndrome (AIDS). Neurology, 44, 892–900.
Ickovics, J. R., & Rodin, J. (1992). Women and AIDS in the United States: Epidemiology, natural history,and mediating mechanisms. Health Psychology, 11(1), 1–16.
Inouye, S. K., Albert, M. S., Mohs, R., Sun, K., & Berkman, L. F. (1993). Cognitive performance in a high-functioning community-dwelling elderly population. Journal of Gerontology, 48, M146–M151.
Janssen, R. S., Okey, C. N., Selik, R. M., & Stehr-Green, J. K. (1992). Epidemiology of human immunodeficiency virus encephalopathy in the United States. Neurology, 42, 1472–1476.
Jarvik, J. G., Lenkinski, R. E., Grossman, R. I., Gomory, J. M., Schnall, M. D., & Frank, I. (1993). Proton MR spectroscopy of HIV-infected patients: Characterization of abnormalities with imaging and clinical correlation. Radiology, 186, 739–744.
Jarvik, J. G., Lenkinski, R. E., Saykin, A. J., Jaans, A., & Frank, I. (1996). Proton spectroscopy in asymptomatic HIV-infected adults: Initial results in a prospective cohort study. Journal of AcquiredImmune Deficiency Syndromes and Human Retrovirology, 13, 247–253.
Jernigan, T. L., Archibald, S., Hesselink, J. R., Atkinson, J. H., Velin, R. A., McCutchan, J. A., Chandler, J.,Grant, I., & the HNRC Group. (1993). Magnetic resonance imaging morphometric analysis of cerebral volume loss in human immunodeficiency virus infection. Archives of Neurology, 50, 250–255.
Kaplan, R. M., Anderson, J. P., Patterson, T. L., McCutchan, J. A., Weinrich, J. D., Heaton, R. K., Atkinson,J. H., Thai, L., Chandler, J., Grant, I., & the HNRC Group. (1995). Validity of the Quality of Well-Being Scale for persons with human immunodeficiency virus infection. Psychosomatic Medicine, 57,138–147.
Kaufman, A. S., McClean, J. E., & Reynolds, C. R. (1988). Sex, race, residence, region, and education differences on the 11 WAIS-R subtests. Journal of Clinical Psychology, 44, 231–248.
Lei, S. Z., Zhang, D., Abele, A. E., & Lipton, S. A. (1992). Blockade of NMDA receptor-mediated mobilization of intracellular Ca prevents neurotoxicity. Brain Research, 598, 196–202.
Leserman, J., Petitto, J. M., Perkins, D. O., Folds, J. D., Golden, R. N., & Evans, D. L. (1997). Severe stress,depressive symptoms, and changes in lymphocyte subsets in human immunodeficiency virus-infected men. A 2-year follow-up study. Archives of General Psychiatry, 54, 279–285.
Letendre, S., Ellis, R., Heaton, R. K., Atkinson, J. H., Nelson, J., Grant, I., & McCutchan, J. A. (1998).Change in CSF RNA level correlates with effects of antiretroviral therapy on HIV-1 associated neurocognitive disorder [Abstract]. Journal of Neurovirology, 4, 357.
Lipton, S. A., & Rosenberg, P. A. (1994). Excitatory amino acids as a final common pathway for neurologic disorders. New England Journal of Medicine, 330, 613–622.
Lyketsos, C. G., Hoover, D. R., Guccione, M., Dew, M. A., Wesch, J. E., Bing, E. G., & Treisman, G. J. (1996).Changes in depressive symptoms as AIDS develops. The Multicenter AIDS Cohort Study. American Journal of Psychiatry, 153, 1430–1437.
Maj, M. (1990). Psychiatric aspects of HIV-1 infection and AIDS. Psychological Medicine, 20, 547–563.
Maj, M., Satz, P., Janssen, R., Zaudig, M., Starace, F., D’Elia, L., Sughondhabirom, B., Mussa, M., Naber,D., & Ndetei, D. (1994). WHO Neuropsychiatric AIDS study, cross-sectional phase II. Neuropsy-chological and neurological findings. Archives of General Psychiatry, 51, 51–61.
Marcotte, T. D., Heaton, R. K., Wolfson, T., Taylor, M. J., Alhassoon, O., Arfaa, K., Ellis, R. J., Grant, I., & the HNRC Group. (1999). The impact of HIV-related neuropsychological dysfunction on driving behavior. Journal of the International Neuropsychological Society, 5, 579–592.
Martin, E. M., Robertson, L., Edelstein, H., Jagust, W., & Sorensen, D. J. (1992a). Performance of patients with early HIV-1 infection on the Stroop task. Journal of Clinical and Experimental Neuropsychology, 14, 857–868.
Martin, E. M., Sorensen, D. J., Edelstein, H. E., & Robertson, L. C. (1992b). Decision-making speed in early HIV-1 infection: A preliminary report. AIDS, 6, 109–113.
Martin, E. M., Sorensen, D. J., Robertson, L. C., Edelstein, H. E., & Chirurgi, V. A. (1992c). Spatialattention in HIV-1 infection: A preliminary report. Journal of Neuropsychiatry and Clinical Neuro-sciences, 4, 1–6.
Martin, E. M., Robertson, L. C, Edelstein, H. E., Jagust, W. J., Sorensen, D. J., San Giovanni, D., &Chirurgi, V. A. (1993). Speed of memory scanning is not affected in early HIV-1 infection. Journal of Clinical and Experimental Neuropsychology, 15, 311–320.
Martin, E. M., Cook, J. A., Cohen, M., Carson, V., Reed, R., Hershow, R., & Burke, J. (1999). Working memory function in HIV-seropositive women: The Women’s Interagency HIV Study [Abstract].Journal of the International Neuropsychological Society, 5, 155.
Masliah, E., Achim, C. L., Ge, N., DeTeresa, R., Terry, R. D., & Wiley, C. A. (1992a). Spectrum of human immunodeficiency virus-associated neocortical damage. Annals of Neurology, 32, 321–329.
Masliah, E., Ge, N., Morey, M., DeTeresa, R., Terry, R. D., & Wiley, C. A. (1992b). Cortical dendriticpathology in human immunodeficiency virus encephalitis. Laboratory Investigation, 66, 285–291.
Masliah, E., Achim, C., DeTeresa, R., Ge, N., & Wiley, C. A. (1994). Cellular neuropathology in HIV encephalitis. In R. W. Price (Ed.), HIV, AIDS and the brain (pp. 119–131). New York: Raven Press.
Masliah, E., Ge, N., Achim, C. L., & Wiley, C. A. (1996). Patterns of neurodegeneration in HIV encephalitis. Journal of Neuro-AIDS, 1(1), 161–173.
Masliah, E., Heaton, R. K., Marcotte, T. D., Ellis, R. J., Wiley, C. A., Mallory, M., Achim, C. L.,McCutchan, J. A., Nelson, J. A., Atkinson, J. H., Grant, I., & the HNRC Group. (1997). Dendritic in jury is a pathologic substrate for HIV-related cognitive disorders. Annals of Neurology, 42, 963–972.
Mayeux, R., Stern, Y., Tang, M.-X., Todak, G., Marder, K., Sano, J., Richards, M., Stein, Z., Ehrhardt, A., & Gorman, J. (1993). Mortality risks in gay men with human immunodeficiency virus infection and cognitive impairment. Neurology, 43, 176–182.
McArthur, J. (1987). Neurologic manifestations of AIDS. Medicine (Baltimore), 66, 407–437.
McArthur, J. C., & Grant, I. (1998). HIV neurocognitive disorders. In H. E. Gendelman, S. Lipton, L.Epstein, & S. Swindells (Ed.), Neurology of AIDS (pp. 499–524). New York: Chapman & Hall.
McArthur, J. C., Cohen, B. A., Seines, O. A., Kumar, A. J., Cooper, K., McArthur, J. H., Soucy, G.,Cornblath, D. R., Chmiel, J. S., Wang, M., Starkey, D. L., Ginzburg, H., Ostrow, D. G., Johnson, R. T.,Phair, J. P., & Polk, B. F. (1989). Low prevalence of neurological and neuropsychological abnor-malities in otherwise healthy HIV-1 infected individuals: Results from the Multicenter AIDS Cohort Study. Annals of Neurology, 26, 601–611.
McArthur, J. C., Hoover, D. R., Bacellar, H., Miller, E. N., Cohen, B. A., Becker, J. T., Graham, N. M. H., McArthur, J. H., Seines, O. A., Jacobson, L. P., Visscher, B. R., Concha, M., & Saah, A. (1993).Dementia in AIDS patients: Incidence and risk factors. Neurology, 42, 1707–1712.
Mellors, J. W., Rinaldo, C. R., Gupta, P., White, R. M., Todd, J. A., & Kingsley, L. A. (1996). Prognosis of HIV-1 infection predicted by the quantity of virus in plasma. Science, 272, 1167–1170.
Miller, E. N., Seines, O. A., McArthur, J. C., Satz, P., Becker, J. T., Cohen, B. A., Sheridan, K., Machado, A.M., Van Gorp, W. G., & Visscher, B. (1990). Neuropsychological performance in HIV-1 infected homosexual men: The Multicenter AIDS Cohort Study (MACS). Neurology, 40, 197–203.
Miller, E., Satz, P., & Visscher, B. (1991). Computerized and conventional neuropsychological assessment of HIV-1 infected homosexual men. Neurology, 41, 1608–1616.
Miller, E. N., Bing, E. G., Seines, O. A., Wesch, J., & Becker, J. T. (1993). The effects of sociodemographic factors on reaction time and speed of information processing [Abstract]. Journal of Clinical and Experimental Neuropsychology, 15, 66.
Miller, S. W., Heaton, R. K., Kirson, D., & Grant, I. (1997). Neuropsychological assessment of African Americans [Abstract]. Journal of the International Neuropsychological Society, 3, 49.
Navia, B. A., & Price, R. W. (1987). The acquired immunodeficiency syndrome dementia complex as the presenting or sole manifestation of human immunodeficiency virus infection. Archives of Neurology, 44, 65–69.
Navia, B. A., Cho, E.-S., Petito, C. K., & Price, R. W. (1986a). The AIDS dementia complex: II. Neuro-pathology. Annals of Neurology, 19, 525–535.
Navia, B. A., Jordan, B. D., & Price, R. W. (1986b). The AIDS dementia complex: I. Clinical features.Annals of Neurology, 19, 517–524.
Navia, B. A., Dafni, U., Simpson, D., Tucker, T., Singer, E., McArthur, J. C., Yiannoutsos, C., Zaborski, L.,Lipton, S. A., & the AIDS Clinical Trial Group. (1998). A phase I/II trial of nimodipine for HIV-related neurologic complications. Neurology, 51, 221–228.
Nordic Medical Research Council’s HIV Therapy Group. (1992). Double blind, dose-response study of zidovudine in AIDS and advance: HIV infection. British Medical Journal, 304, 13–17.
Ostrow, D. G., Monjan, A., Joseph, J., VanRaden, M., Fox, R., Kingsley, L., Dudley, J., & Phair, J. (1989).HIV-related symptoms and psychological functioning in a cohort of homosexual men. American Journal of Psychiatry, 146, 737–742.
Peavy, G., Jacobs, D., Salmon, D. P., Butters, N., Delis, D. C., Taylor, M., Massman, P., Stout, J. C., Heindel,W. G., Kirson, D., Atkinson, J. H., Chandler, J. L., & Grant, I. (1994). Verbal memory performance of patients with human immunodeficiency virus infection: Evidence of subcortical dysfunction.Journal of Clinical and Experimental Neuropsychology, 16, 508–523.
Perdices, M. A., & Cooper, D. A. (1989). Simple and choice reaction time in patients with human immunodeficiency virus infection. Annals of Neurology, 25, 460–467.
Perkins, D. O., Stern, R. A., Golden, R. N., Murphy, C., Naftolowitz, D., & Evans, D. L. (1994). Mood disorders in HIV infection: Prevalence and risk factors in a nonepicenter of the AIDS epidemic.American Journal of Psychiatry, 151, 233–236.
Perry, S., Jacobsberg, L. B., Fishman, B., Frances, A., Bobo, J., & Jacobsberg, B. K. (1990). Psychiatric diagnosis before serological testing for the human immunodeficiency virus. American Journal of Psychiatry, 147, 89–93.
Portegies, P., de Gans, J., Lange, J. M. A., Derix, M. M. A., Speelman, H., Bakker, M., Danner, S. A., & Goudsmit, J. (1989). Declining incidence of AIDS dementia complex after introduction of zidovudine treatment. British Medical Journal, 299, 819–821.
Post, M. J. D., Berger, J. R., & Qeuncer, R. M. (1991). Asymptomatic and neurologically symptomatic HIV-seropositive individuals: Prospective evaluation with cranial MR imaging. Radiology, 178,131–139.
Price, R. W., & Brew, B. J. (1988). The AIDS dementia complex. Journal of Infectious Diseases, 158, 1079–1083.
Prevalence of psychiatric disorders in HIV illness. International Review of Psychiatry, 8, 157–166.
Rabkin, J. G., & Ferrando, S. (1997). A “second life” agenda. Psychiatric research issues raised by protease inhibitor treatments for people with the human immunodeficiency virus or the acquired immunodeficiency syndrome. Archives of General Psychiatry, 54, 1049–1053.
Rabkin, J. G., Goetz, R. R., Remien, R. H., Williams, J. B., Todak, G., & Gorman, J. M. (1997a). Stability of mood despite HIV illness progression in a group of homosexual men [see comments]. American Journal of Psychiatry, 154, 231–238.
Rabkin, J. G., Johnson, J., Lin, S. H., Lipsitz, J. D., Remien, R. H., Williams, J. B., & Gorman, J. M. (1997b).Psychopathology in male and female HIV-positive and negative injecting drug users: Longitudinal course over 3 years. AIDS, 11, 507–515.
Reed, G. M., Kemeny, M. E., Taylor, S. E., & Visscher, B. R. (1999). Negative HIV-specific expectancies and AIDS-related bereavement as predictors of symptom onset in asymptomatic HIV-positive gaymen. Health Psychology, 18, 354–363.
Reicks, C. J., Moore, D. J., Dawson, L. K., Marcotte, T. D., Heaton, R. K., Grant, I., & the HNRC Group.(1999). Neuropsychological performance predicts everyday functioning in HIV + individuals [Abstract]. Journal of the International Neuropsychological Society, 5, 155.
Rosenberger, P. H., Bornstein, R. A., Nasrallah, H. A., Para, M. F., Whitaker, C. C., Fass, R. J., & Rice, R. R.,Jr. (1993). Psychopathology in human immunodeficiency virus infection: Lifetime and current assessment. Comprehensive Psychiatry, 34(3), 150–158.
Rosenblum, M. L., Levy, R. M., Bredesen, D. E., So, Y. T., Wara, W., & Ziegler, J. L. (1988). Primary central nervous system lymphomas in patients with AIDS. Annals of Neurology, 23, S13–S16.
Rottenberg, D. A., Moeller, J. R., Strother, S. C., Sidtis, J. J., Navia, B. A., Dhawan, V., Ginos, Z., & Price, R.W. (1987). The metabolic pathology of the AIDS dementia complex. Annals of Neurology, 22,700–706.
Rounsaville, B. J., Weissman, M. M., Kleber, H., & Wilber, C. (1982). Heterogeneity of psychiatric diagnosis in treated opiate addicts. Archives of General Psychiatry, 39, 161–168.
Sahakian, B. J., Elliot, R., Low, N., Mehta, M., Clark, R. T., & Pozniak, A. L. (1995). Neuropsychological deficits in tests of executive function in asymptomatic and symptomatic HIV-1 seropositive men.Psychological Medicine, 25, 1233–1246.
Satz, P. (1993). Brain reserve capacity on symptom onset after brain injury: A formulation and review of evidence for threshold theory. Neuropsychology, 7, 273–295.
Satz, P., Morgenstern, H., Miller, E. N., Seines, O. A., McArthur, J. C., Cohen, B. A., Wesch, J., Becker, J.T., Jacobsen, L., D’Elia, L. F., van Gorp, W., & Visscher, B. (1993). Low education as a possible risk factor for cognitive abnormalities in HIV-1: Findings from the Multicenter AIDS Cohort Study(MACS). Journal of Acquired Immune Deficiency Syndrome, 6, 503–511.
Schmitt, F. A., Bigley, J. W., McKinnis, R., Logue, P. E., Evans, R. W., Drucker, J. L., & the AZT Collaborative Working Group. (1988). Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex. New England Journal of Medicine, 319, 1573–1578.
Seines, O. A., Miller, E., McArthur, J., Gordon, B., Muñoz, A., Sheridan, K., Fox, R., Saah, A. J., & the Multicenter AIDS Cohort Study. (1990). HIV-1 infection: No evidence of cognitive decline during the asymptomatic stages. Neurology, 40, 204–208.
Seines, O. A., Galai, N., Bacellar, H., Miller, E. N., Becker, J. T., Wesch, J., van Gorp, W., & McArthur, J. C.(1995). Cognitive performance after progression to AIDS: A longitudinal study from the Multicenter AIDS Cohort Study. Neurology, 45, 267–275.
Sewell, D. D., Jeste, D. V., Atkinson, J. H., Heaton, R. K., Hesselink, J. R., Wiley, C., Thai, L., Chandler, J.L., Grant, I., & the San Diego HIV Neurobehavioral Research Center Group. (1994). HIV-associated psychosis: A study of 20 cases. American Journal of Psychiatry, 151, 237–242.
Sonnerborg, A. B., Ehrnst, A. C., Bergdahl, S. K., Pehrson, P. O., Skoldenberg, B. R., & Strannegard, O. O.(1988). HIV isolation from cerebrospinal fluid in relation to immunological deficiency and neurological symptoms. AIDS, 2, 89–93.
Stern, Y., Marder, K., Bell, K., Chen, J., Dooneief, G., Goldstein, S., Mindry, D., Richards, M., Sano, M.,Williams, J., Gorman, J., Ehrhardt, A., & Mayeux, R. (1991). Multidisciplinary assessment of homo-sexual men with and without human immunodeficiency virus infection. III. Neurologic and neuropsychological findings. Archives of Neurology, 48, 131–138.
Stern, R. A., Arruda, J. E., Somerville, J. A., Cohen, R. A., Boland, R. J., Stein, M. D., & Martin, E. M.(1998). Neurobehavioral functioning in asymptomatic HIV-1 infected women. Journal of the International Neuropsychological Society, 4, 172–178.
Stout, J. C., Ellis, R. J., Jernigan, T. L., Archibald, S. L., Abramson, I., Wolfson, T., McCutchan, J. A.,Wallace, M. R., Atkinson, J. H., Grant, I., & the HNRC Group. (1998). Progressive cerebral volumeloss in human immunodeficiency virus infection: A longitudinal volumetric MRI study. Archives of Neurology, 55, 161–168.
Tracey, I., Carr, C. A., Guimaraes, A. R., Worth, J. L., Navia, B. A., & Gonzalez, R. G. (1996). Brain choline-containing compounds are elevated in HIV-positive patients before the onset of AIDS dementia complex: A proton magnetic resonance spectroscopic study. Neurology, 46, 783–788.
United Nations Programme on HIV/AIDS, and World Health Organization. (1998). AIDS epidemic update: December 1998. Geneva: Author.
United Nations Programme on HIV/AIDS, and World Health Organization. (2000). Report on the global HIV/AIDS epidemic. Geneva: Author.
US Department of Labor. (1991). Dictionary of occupational titles (4th ed.). Washington, DC: US Government Printing Office.
van der Horst, C. M., Saag, M. S., Cloud, G. A., Hamill, R. J., Graybill, J. R., Sobel, J. D., Johnson, P. C.,Tuazon, C. U., Kerkering, T., Moskovitz, B. L., Powderly, W. G., & Dismukes, W. E. (1997). Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group[see comments]. New England Journal of Medicine, 337, 15–21.
Van Dyck, C. H., McMahon, T. J., Rosen, M. I., O’Malley, S. S., O’Connor, P. G., Lin, C. H., Pearsall, H. R.,Woods, S. W., & Kosten, T. R. (1997). Sustained-release methylphenidate for cognitive impairment in HIV-1-infected drug abusers: A pilot study. Journal of Neuropsychiatry and Clinical Neuro-sciences, 9, 29–36
van Gorp, W., Satz, P., Hinkin, C., Seines, O., Miller, E., McArthur, J., Cohen, B., & Paz, D. (1991).Metacognition in HIV-1 seropositive asymptomatic individuals: Self-ratings versus objective neuropsychological performance. Journal of Clinical and Experimental Neuropsychology, 13, 812–819.
van Gorp, W. G., Mandelkern, M. A., Gee, M., Hinkin, C. H., Stern, C. E., Paz, D. K., Dixon, W., Evans, G.,Flynn, F., Frederick, C. J., Ropchan, J. R., & Blahd, W. H. (1992). Cerebral metabolic dysfunction in AIDS: Findings in a sample with and without dementia. Journal of Neuropsychiatry and Clinical Neurosciences, 4, 280–287.
van Gorp, W. G., Miller, E. N., Marcotte, T. D., Dixon, W., Paz, D., Seines, O., Wesch, J., Becker, J. T.,Hinkin, C. H., Mitrushina, M., Satz, P., Weisman, J. D., & Stenquist, P. K. (1994). The relationship between age and cognitive impairment in HIV-1 infection: Findings from the Multicenter AIDS Cohort Study and a clinical cohort. Neurology, 44, 929–935.
Weis, S., Haug, H., & Budka, H. (1993). Neuronal damage in the cerebral cortex of AIDS brains: Amorphometric study. Acta Neuropathologica (Berlin), 85(2), 185–189.
White, D. A., Heaton, R. K., & Monsch, A. U. (1995). Neuropsychological studies of asymptomatic Human Immunodeficiency Virus-Type 1-infected individuals. Journal of the International Neuropsychological Society, 1, 304–315.
Wiley, C. A., & Achim, C. (1995). Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome Ann Neurol, 37:140
Wiley, C. A., & Achim, C. (1994). Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome Annals of Neurology, 36, 673–676.
Wiley, C. A., Schrier, R. D., Denaro, F. J., Nelson, J. A., Lampert, P. W., & Oldstone, M. B. (1986a).Localization of cytomegalovirus proteins and genome during fulminant central nervous system infection in an AIDS patient. Journal of Neuropathology and Experimental Neurology, 45, 127–139.
Wiley, C. A., Schrier, R. D., Nelson, J. A., Lampert, P. W., & Oldstone, M. B. (1986b). Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proceedings of the National Academy of Sciences USA, 83, 7089–7093.
Wiley, C., Masliah, E., Morey, M., Lemere, C., DeTeresa, R., Grafe, M., Hansen, L., & Terry, R. (1991).Neocortical damage during HIV infection. Annals of Neurology, 29, 651–657.
Wilkie, F. L., Eisdorfer, C., Morgan, R., Loewenstein, D. A., & Szapocznik, J. (1990). Cognition in early human immunodeficiency virus infection. Archives of Neurology, 47, 433–440.
Wilkins, J. W., Robertson, K. R., Snyder, C. R., Robertson, W. K., van der Horst, C., & Hall, C. D. (1991).Implications of self-reported cognitive and motor dysfunction in HIV-positive patients. American Journal of Psychiatry, 148, 641–643.
Williams, J. B., Rabkin, J. G., Remien, R. H., Gorman, J. M., & Ehrhardt, A. A. (1991). Multidisciplinary baseline assessment of homosexual men with and without human immunodeficiency virus infection. II. Standardized clinical assessment of current and lifetime psychopathology. Archives of General Psychiatry, 48, 124–130.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Marcotte, T.D., Grant, I., Atkinson, J.H., Heaton, R.K. (2001). Neurobehavioral Complications of HIV Infection. In: Tarter, R.E., Butters, M.A., Beers, S.R. (eds) Medical Neuropsychology. Critical Issues in Neuropsychology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1287-5_13
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1287-5_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5479-6
Online ISBN: 978-1-4615-1287-5
eBook Packages: Springer Book Archive